Compare WLDN & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WLDN | ALMR |
|---|---|---|
| Founded | 1964 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | 2006 | 2026 |
| Metric | WLDN | ALMR |
|---|---|---|
| Price | $84.57 | $33.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $114.50 | N/A |
| AVG Volume (30 Days) | 243.1K | ★ 279.7K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 120.89 | N/A |
| EPS | ★ 2.13 | N/A |
| Revenue | ★ $273,352,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.05 | N/A |
| P/E Ratio | $39.69 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $64.67 | $21.58 |
| 52 Week High | $137.00 | $38.54 |
| Indicator | WLDN | ALMR |
|---|---|---|
| Relative Strength Index (RSI) | 59.03 | 64.11 |
| Support Level | $82.67 | $23.69 |
| Resistance Level | $86.28 | $38.54 |
| Average True Range (ATR) | 3.74 | 2.73 |
| MACD | 1.39 | 0.52 |
| Stochastic Oscillator | 79.79 | 61.57 |
Willdan Group Inc is a technical services company focused on energy and infrastructure solutions. The company's solutions include energy planning and analytics, consulting, software, public finance, engineering, and program implementation. It operates through two segments: i) Energy segment: It provides specialized, comprehensive energy solutions to businesses, utilities, state agencies, municipalities, and non-profit organizations. ii) Engineering & Consulting: It provides civil engineering and construction management, building and safety services, city engineering and planning support, civil design, geotechnical services, and material testing. The majority of revenue is derived from the Energy segment. Geographically, all of the company's revenue is generated from the United States.
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.